Aminoglycoside therapy: current and prospective uses.
作者信息
Leggett J E
机构信息
The Department of Medical Education, Providence Medical Center, Portland, Oregon 97213-2967, USA.
出版信息
Tex Heart Inst J. 1990;17(4):330-6.
Abstract
摘要
相似文献
1
Aminoglycoside therapy: current and prospective uses.
Tex Heart Inst J. 1990;17(4):330-6.
2
A practical approach enabling staff pharmacists to prospectively review and dose aminoglycoside therapy.
Hosp Pharm. 1988 Nov;23(11):976-8, 981-3.
3
Aminoglycoside therapy in infectious diseases.
Expert Opin Pharmacother. 2013 Aug;14(12):1585-97. doi: 10.1517/14656566.2013.806486. Epub 2013 Jun 8.
4
Influence of multiple courses of therapy on aminoglycoside clearance in adult patients with cystic fibrosis.
J Antimicrob Chemother. 2013 Jun;68(6):1338-47. doi: 10.1093/jac/dkt035. Epub 2013 Feb 23.
5
Does aminoglycoside therapy cause significant acute kidney injury in febrile neutropenia?
Int J Antimicrob Agents. 2011 Jan;37(1):78-81. doi: 10.1016/j.ijantimicag.2010.08.017.
6
Antibiotic use in neonatal sepsis.
Turk J Pediatr. 1998 Jan-Mar;40(1):17-33.
7
The role of aminoglycosides in combination with a beta-lactam for the treatment of bacterial endocarditis: a meta-analysis of comparative trials.
J Antimicrob Chemother. 2006 Apr;57(4):639-47. doi: 10.1093/jac/dkl044. Epub 2006 Feb 24.
8
Modification of Diet in Renal Disease and modified Cockcroft-Gault formulas in predicting aminoglycoside elimination.
Ann Pharmacother. 2008 Dec;42(12):1758-65. doi: 10.1345/aph.1L144.
9
Effect of aminoglycoside and beta-lactam combination therapy versus beta-lactam monotherapy on the emergence of antimicrobial resistance: a meta-analysis of randomized, controlled trials.
Clin Infect Dis. 2005 Jul 15;41(2):149-58. doi: 10.1086/430912. Epub 2005 May 31.
引用本文的文献
1
Correlation of the pharmacokinetic parameters of amikacin and ceftazidime.
Clin Pharmacokinet. 2007;46(10):859-66. doi: 10.2165/00003088-200746100-00004.
本文引用的文献
1
Aminoglycoside nephrotoxicity.
Kidney Int. 1980 Nov;18(5):571-82. doi: 10.1038/ki.1980.175.
2
Gentamicin dosing errors with four commonly used nomograms.
JAMA. 1982 Sep 10;248(10):1190-3.
3
Penetration of antibiotics into respiratory secretions.
Rev Infect Dis. 1981 Jan-Feb;3(1):67-73. doi: 10.1093/clinids/3.1.67.
4
Staphylococcus epidermidis causing prosthetic valve endocarditis: microbiologic and clinical observations as guides to therapy.
Ann Intern Med. 1983 Apr;98(4):447-55. doi: 10.7326/0003-4819-98-4-447.
5
Aminoglycoside-resistant mutants of Pseudomonas aeruginosa deficient in cytochrome d, nitrite reductase, and aerobic transport.
Antimicrob Agents Chemother. 1981 Jun;19(6):958-64. doi: 10.1128/AAC.19.6.958.
6
Combination antimicrobial therapy for Staphylococcus aureus endocarditis in patients addicted to parenteral drugs and in nonaddicts: A prospective study.
Ann Intern Med. 1982 Oct;97(4):496-503. doi: 10.7326/0003-4819-97-4-496.
7
The association of aminoglycoside plasma levels with mortality in patients with gram-negative bacteremia.
J Infect Dis. 1984 Mar;149(3):443-8. doi: 10.1093/infdis/149.3.443.
8
Synergy of combinations of vancomycin, gentamicin, and rifampin against methicillin-resistant, coagulase-negative staphylococci.
Antimicrob Agents Chemother. 1983 Jun;23(6):932-4. doi: 10.1128/AAC.23.6.932.
9
Effect of the pH and osmolality of urine on the antibacterial activity of gentamicin.
J Antimicrob Chemother. 1983 Dec;12(6):571-5. doi: 10.1093/jac/12.6.571.
10
Bioactivity of gentamicin in purulent sputum from patients with cystic fibrosis or bronchiectasis: comparison with activity in serum.
J Infect Dis. 1983 Dec;148(6):1069-76. doi: 10.1093/infdis/148.6.1069.
Zotero 插件